Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 166 participants.

Also called NCT04982367

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 166 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04982367
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04982367. Randomized; no masking; primary purpose treatment. Start 2021-12-08 (actual); primary completion 2024-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis
Condition
Peripheral Artery Disease
Intervention (Device)
Sirolimus-eluting balloon catheter
Intervention (Device)
Paclitaxel-eluting balloon catheter
Lead sponsor
Acotec Scientific Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct04982367
Content hash
b2e8a152d7bd5a011e0f267d3eb6a38b8fc01c81d232917156197637299e7338